Page last updated: 2024-08-21

triphenyltetrazolium and Angiogenesis, Pathologic

triphenyltetrazolium has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baffour, R; Berman, J; Friedmann, P; Garb, JL; Kaufman, J; Rhee, SW1

Other Studies

1 other study(ies) available for triphenyltetrazolium and Angiogenesis, Pathologic

ArticleYear
Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor.
    Journal of vascular surgery, 1992, Volume: 16, Issue:2

    Topics: Acute Disease; Analysis of Variance; Animals; Blood Gas Monitoring, Transcutaneous; Collateral Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2; Hindlimb; Ischemia; Ligation; Male; Neovascularization, Pathologic; Rabbits; Radiography; Recombinant Proteins; Spectrophotometry; Tetrazolium Salts

1992